Table 1.
Source | Design | Setting | Sample | Timing of intervention | Intervention focus | Comparator | Follow-up |
---|---|---|---|---|---|---|---|
Alibhai 2019 [47] | 3-arm feasibility RCT |
Canada Hospital or home |
59 men with prostate cancer mean age 70 (range 62–90) | Starting or continuing ADT | Activity | Non-inferiority comparison between home-based activity (HOME; intervention group), group-based face-to-face (GROUP), and 1:1 personal training (PT). | 3- and 6-month follow-ups (not reported in this paper) |
Bourke 2011 [48] | 2-arm feasibility RCT |
UK Home or supervised (unknown whether hospital or community) |
50 men with localised prostate cancer mean age 72 (range 60–87) | receiving AST for at least 6 months | Nutrition and activity | Usual care | 6 months |
Demark-Wahnefried 2006 [49] | 2-arm RCT |
USA Home |
182 breast and prostate cancer patients Mean age 72 (range 65–91) |
Within 18 months of diagnosis | Nutrition and activity | Attention control Received workbook with general health promotion materials. Also received phone counselling (same schedule) that was structured around a specific health topic as addressed in workbook. | 12 months |
Demark-Wahnefried 2018 [50] | 2-arm feasibility RCT |
USA Home |
46 mixed cancer survivors Mean age 70 (range 60–92) |
Post treatment (exception for adjuvant endocrine therapy) | Nutrition | Wait list control Matched with MGs, given all materials and monitored for year 2 after 1 year wait-list. | 24 months |
Desbiens 2017 [51] | 2-arm pilot RCT |
Canada Home or hospital based |
26 breast cancer currently on aromatase inhibitor therapy | No RT for at least 1 month | Activity | Active comparator Same activity routine in group setting. | None |
Lai 2017 [52] | 2-arm RCT |
China Hospital |
60 lung cancer patients | Pre-surgery | Activity | Usual care | None |
Loh 2019 [53] | 2-arm RCT |
USA Hospital |
252 mixed cancer patients | currently or soon be receiving chemotherapy | Activity | Wait list control Given the intervention kit for free at the end of the study | None |
Miki 2014 [54] | 2-arm feasibility RCT |
Japan Hospital |
78 breast (43) and prostate (35) cancer | Majority post treatment 5 chemo, 2 radiation, 41 hormone | Activity | Usual care | None |
Monga 2007 [55] | 2-arm feasibility RCT |
USA Hospital |
21 localised prostate cancer patients | Receiving radiotherapy | Activity | Usual care plus general education | None |
Morey 2009 [56] | 2-arm RCT |
USA (small number from UK and Canada) Home |
641 breast, prostate, and colorectal cancer survivors randomised Mean age 73 (no range) |
5 or more years post diagnosis (considered to be cured) | Nutrition and Activity | Wait list control Usual care until 1 year when they received the full intervention. | 24 months |
Park 2012 [57] | 2-arm RCT |
Korea University |
66 localised prostate cancer patients randomised Mean age 69 (no range) |
post prostatectomy; excluded if any adjuvant or neoadjuvant therapy | Activity | Usual care plus kegel exercises only. | None |
Porserud 2014 [58] | 2-arm feasibility RCT |
Sweden University hospital |
18 bladder cancer patients randomised Mean age 72 (range 64–78) |
After undergoing radical cystectomy for bladder cancer | Activity | Wait list control Usual care during study period offered same programme after data collection was complete. | 12 months |
Sprod 2015 [59] | 2-arm RCT |
USA Community, Cancer centre |
97 older (≥ 60) mixed cancer survivors randomised Mean age 66 (no range) |
completed standard treatment 2–24 months prior | Activity | Wait list control Offered opportunity to participate in sessions post study. | None |
Winters-Stone 2016 [60] | 2-arm feasibility RCT |
USA University |
64 prostate cancer survivors and their spouse or partner (64 couples) randomised Mean age of PCS 72; mean age of spouses 68 |
received treatment for PCS but not currently on CT or RT | Activity | Wait list control Received home-based instructional video of the programme and an instructional workshop post-study | None |
QoL quality of life, RCT randomised controlled trial, UK United Kingdom, USA United States of America, ADT androgen deprivation therapy, AST androgen suppression therapy, PT personal training, MG master gardener, PCS prostate cancer survivors, CT chemotherapy, RT radiotherapy